COSTA MESA, CA--(Marketwire - November 05, 2008) - CNS Response, Inc. (OTCBB: CNSO) reported today the results of a study presented at the U.S. Psychiatric and Mental Health Congress by Daniel Hoffman, M.D., Chief Medical Officer for CNS Response and six other psychiatrists. The poster presentation, titled "Medication Washout: Imposing Discontinuation of A Diagnostic and Therapeutic Tool?" provides an analysis of the combined experiences of these psychiatrists who routinely 'washout' patients to perform a CNS Response rEEG® analysis or to develop a baseline understanding of a patient's behavior without medication influence.
